15 samples
Export
<<<Page of 1 >>>
Accession Title Sample type Organism(s) Ch Platform Series Supplementary Contact Release date
Remove filtersFilter Remove filterGSE224435
GSM7022172
luminal breast cancer, untreated, rep1
SRA 1
  • Link icon GSE224435
Sandra Casimiro Jun 09, 2023
GSM7022173
luminal breast cancer, untreated, rep2
SRA 1
  • Link icon GSE224435
Sandra Casimiro Jun 09, 2023
GSM7022174
luminal breast cancer, palbocicib + fulvestrant, rep1
SRA 1
  • Link icon GSE224435
Sandra Casimiro Jun 09, 2023
GSM7022175
luminal breast cancer, palbocicib + fulvestrant, rep2
SRA 1
  • Link icon GSE224435
Sandra Casimiro Jun 09, 2023
GSM7022176
luminal breast cancer, palbocicib + fulvestrant + OPG-Fc, rep1
SRA 1
  • Link icon GSE224435
Sandra Casimiro Jun 09, 2023
GSM7022177
luminal breast cancer, palbocicib + fulvestrant + OPG-Fc, rep2
SRA 1
  • Link icon GSE224435
Sandra Casimiro Jun 09, 2023
GSM7022178
luminal breast cancer, palbocicib + fulvestrant + OPG-Fc, rep3
SRA 1
  • Link icon GSE224435
Sandra Casimiro Jun 09, 2023
GSM7022179
luminal breast cancer RANK OE, untreated, rep1
SRA 1
  • Link icon GSE224435
Sandra Casimiro Jun 09, 2023
GSM7022180
luminal breast cancer RANK OE, untreated, rep2
SRA 1
  • Link icon GSE224435
Sandra Casimiro Jun 09, 2023
GSM7022181
luminal breast cancer RANK OE, untreated, rep3
SRA 1
  • Link icon GSE224435
Sandra Casimiro Jun 09, 2023
GSM7022182
luminal breast cancer RANK OE, palbocicib + fulvestrant, rep1
SRA 1
  • Link icon GSE224435
Sandra Casimiro Jun 09, 2023
GSM7022183
luminal breast cancer RANK OE, palbocicib + fulvestrant, rep2
SRA 1
  • Link icon GSE224435
Sandra Casimiro Jun 09, 2023
GSM7022184
luminal breast cancer RANK OE, palbocicib + fulvestrant, rep3
SRA 1
  • Link icon GSE224435
Sandra Casimiro Jun 09, 2023
GSM7022185
luminal breast cancer RANK OE, palbocicib + fulvestrant + OPG-Fc, rep1
SRA 1
  • Link icon GSE224435
Sandra Casimiro Jun 09, 2023
GSM7022186
luminal breast cancer RANK OE, palbocicib + fulvestrant + OPG-Fc, rep2
SRA 1
  • Link icon GSE224435
Sandra Casimiro Jun 09, 2023